Skip to content
2000
Volume 21, Issue 17
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

Background

Drug resistance poses a threat to global health given the disturbing rate at which microbiological illnesses are rising and the widespread use of antibiotics. While naturally occurring antibiotics reduce the likelihood of bacterial resistance, recognized drugs can develop the same properties when structurally modified. Metronidazole has been targeted to achieve this feat.

Objective

The purpose of this work is to enable the structural modification of metronidazole by means of electric current, using inexpensive, easily accessible magnesium ribbon as electrodes in order to produce a novel, effective antibiotic.

Methods

With magnesium ribbon electrodes, metronidazole is modified electrochemically, in an undivided cell system. Ultraviolet-visible (UV-Vis), Fourier Transform Infrared (FTIR), and Gas Chromatography-Mass Spectrometry (GC-MS) were used to characterize the product. Antibacterial activity was evaluated using the agar well diffusion method and Wistar rats were used for toxicity assessment.

Results

2-Methyl-1-vinyl-1H-imidazol-5-amine showed good antibacterial activities compared to the standard nitrofurantoin and toxicity evaluations using Wistar rats revealed that the product might induce dose-dependent variations in kidney function biomarkers, with doses of 100 mg/kg and below. However, when the compound was administered orally, there was no significant effect on liver function, even at a dose of 1000 mg/kg.

Conclusion

These results point to the modified metronidazole's potential as a potent antibiotic with controllable toxicity, indicating that additional research into its pharmacological uses is necessary.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/0115701808281133240424055511
2024-04-29
2025-06-20
Loading full text...

Full text loading...

References

  1. RubinL.G. Bacterial colonization and infection resulting from multiplication of a single organism.Clin. Infect. Dis.19879348849310.1093/clinids/9.3.4883299635
    [Google Scholar]
  2. JindalA.K. PandyaK. KhanI.D. Antimicrobial resistance: A public health challenge.Med. J. Armed Forces India201571217818110.1016/j.mjafi.2014.04.01125859082
    [Google Scholar]
  3. The Evolving Threat of Antimicrobial Resistance Options for Action2012Available from: http://whqlibdoc.who.int/publications/2012/9789241503181_eng.pdf
    [Google Scholar]
  4. DeliormanM. JanahiF.K. SukumarP. GliaA. AlnemariR. FadlS. ChenW. QasaimehM.A. AFM-compatible microfluidic platform for affinity-based capture and nanomechanical characterization of circulating tumor cells.Microsyst. Nanoeng.2020612010.1038/s41378‑020‑0131‑934567635
    [Google Scholar]
  5. National Center for Biotechnology Information PubChem Compound Summary for CID 6604200, Nitrofurantoin.2023Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Nitrofurantoin
  6. National Center for Biotechnology Information PubChem Compound Summary for CID 54671203, Doxycycline.2023Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Doxycycline
  7. National Center for Biotechnology Information PubChem Compound Summary for CID 33613, Amoxicillin.2023Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Amoxicillin
  8. EguS.A. OkoroU.C. WirthT. Synthesis of quinolinequinone derivatives and related carbocyclic compounds.ScienceOpen Res.201510.14293/S2199‑1006.1.SOR‑CHEM.AALL9P.v1
    [Google Scholar]
  9. EguS.A. OkoroU.C. OnoabedjeE.A. New aryl derivatives of quinolinedione and related heterocyclic compounds.J. Heterocycl. Chem.20175421572157710.1002/jhet.2745
    [Google Scholar]
  10. AroraS. HazanE. KaleS. The multiplicative weights update method: A meta-algorithm and applications.Theory of computing201281121164
    [Google Scholar]
  11. SearleG. D. Comm, 88 T.C. 252.1987Available from: Leagle.com
    [Google Scholar]
  12. MuraC. ValentiD. FlorisC. SannaR. De LucaM.A. FaddaA.M. LoyG. Metronidazole prodrugs: Synthesis, physicochemical properties, stability, and ex vivo release studies.Eur. J. Med. Chem.20114694142415010.1016/j.ejmech.2011.06.01621726922
    [Google Scholar]
  13. YongJ. LuC. WuX. Synthesis of metronidazole derivatives Containing Pyridine Ring and anticancer activity.Lett. Org. Chem.201613428328810.2174/157017861304160413120220
    [Google Scholar]
  14. BowdenK. IzadiJ. Multifunctional derivatives of metronidazole.Farmaco199853586110.1016/S0014‑827X(97)00007‑4
    [Google Scholar]
  15. Available from: https://www.accessdata.fda.gov/drugsalfda-da/label/2013/01865750321bl
  16. WirtanenT. RodrigoE. WaldvogelS.R. Recent advances in the electrochemical reduction of substrates involving N-O bonds.Adv. Synth. Catal.2020362112088210110.1002/adsc.202000349
    [Google Scholar]
  17. HornE.J. RosenB.R. BaranP.S. Synthetic organic electrochemistry: An enabling and innately sustainable method.ACS Cent. Sci.20162530230810.1021/acscentsci.6b0009127280164
    [Google Scholar]
  18. ChenC.L. Gas Chromatography-Mass Spectrometry (GS-MS). Springer Series in Wood Science199252754810.1007/978‑3‑642‑74065‑7_38
    [Google Scholar]
  19. CheesbroughM. District laboratory practice in tropical countries.Part 2Cambridge university press. LPE.2000
    [Google Scholar]
  20. HammerichO. Reduction of Nitro Compounds and Related Substrates.Organic Electrochemistry5th ednCRC Press (Taylor & Francis Group)Boca Raton201511491200
    [Google Scholar]
  21. OliveiraM.C.F. Study of the hypophosphite effect on the electrochemical reduction of nitrobenzene on Ni.Electrochim. Acta200348131829183510.1016/S0013‑4686(03)00248‑2
    [Google Scholar]
  22. Ashenhurst, J. (2017, February 14). Molecular Orbital Pi Bond. Master Organic Chemistry. https://www.masterorganicchemistry.com/2017/02/14/molecular-orbital-pi-bond/ Retrieved October 10, 2022.
  23. TheuretzbacherU. OuttersonK. EngelA. KarlénA. The global preclinical antibacterial pipeline.Nat. Rev. Microbiol.202018527528510.1038/s41579‑019‑0288‑031745331
    [Google Scholar]
  24. LiuB.G. XieM. DongY. WuH. HeD.D. HuG.Z. XuE.P. Antimicrobial mechanisms of traditional Chinese medicine and reversal of drug resistance: A narrative review.Eur. Rev. Med. Pharmacol. Sci.202226155553556110.26355/eurrev_202208_2942635993652
    [Google Scholar]
  25. LimaC. MacedoE. Urinary biochemistry in the diagnosis of acute kidney injury.Dis. Markers201820181710.1155/2018/490702430008975
    [Google Scholar]
  26. ZhangY. HagenbuchB. Protein-protein interactions of drug uptake transporters that are important for liver and kidney.Biochem. Pharmacol.201916838439110.1016/j.bcp.2019.07.02631381872
    [Google Scholar]
  27. PóvoaP. CoelhoL. Dal-PizzolF. FerrerR. HuttnerA. Conway MorrisA. NobreV. RamirezP. RouzeA. SalluhJ. SingerM. SweeneyD.A. TorresA. WatererG. KalilA.C. How to use biomarkers of infection or sepsis at the bedside: Guide to clinicians.Intensive Care Med.202349214215310.1007/s00134‑022‑06956‑y36592205
    [Google Scholar]
  28. ŠmídV. Liver tests.Cas. Lek. Cesk.20221612525635728957
    [Google Scholar]
  29. EguS.A. AliI. KhanK.M. ChigurupatiS. QureshiU. Ul-HaqZ. SalarU. Syntheses, in silico, kinetics, and in vitro evaluation of potent radical (DPPH and ABTS) scavengers and α-amylase inhibitors of rhodanine based schiff bases.Mol. Divers.202327276779110.1007/s11030‑022‑10454‑035604512
    [Google Scholar]
/content/journals/lddd/10.2174/0115701808281133240424055511
Loading
/content/journals/lddd/10.2174/0115701808281133240424055511
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test